11
TITLE: Adverse Reactions Associated with Comirnaty (R) Among Healthcare Professionals: A Cohort Event Monitoring Study in a Portuguese Hospital
AUTHORS: Tavares, I.; Penedones, A.; Abrantes, J. R.; Mendes, D. ; Codeco, C.; Rigueiro, G.; Alves, C.; Marques, F. B.;
PUBLISHED: 2022, SOURCE: DRUG SAFETY, VOLUME: 45, ISSUE: 10
INDEXED IN: WOS
12
TITLE: JAK inhibitors for atopic dermatitis: A network meta-analysis of adverse events  Full Text
AUTHORS: Penedones, Ana; Alves, Carlos; Mendes, Diogo ; Marques, Francisco Batel;
PUBLISHED: 2022, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 31
INDEXED IN: WOS
13
TITLE: Numbers needed to treat to benefit (nntb) and to harm (nnth) for COVID-19 medicines  Full Text
AUTHORS: Penedones, Ana; Mendes, Diogo ; Alves, Carlos; Marques, Francisco Batel;
PUBLISHED: 2022, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 31
INDEXED IN: WOS
14
TITLE: Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis A Systematic Review and Network Meta-analysis. A Systematic Review and Network Meta-analysis
AUTHORS: Alves, C; Penedones, A; Mendes, D ; Marques, FB;
PUBLISHED: 2022, SOURCE: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, VOLUME: 28, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 20
15
TITLE: The Impact of the COVID-19 Pandemic on Spontaneous Reporting of Adverse Drug Reactions in the Central Region of Portugal
AUTHORS: Abrantes, J. R.; Tavares, I.; Penedones, A.; Figueiredo, D.; Mendes, D. ; Alves, C.; Marques, F. B.;
PUBLISHED: 2022, SOURCE: DRUG SAFETY, VOLUME: 45, ISSUE: 10
INDEXED IN: WOS
16
TITLE: The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis A Systematic Review and Network Meta-analysis. A Systematic Review and Network Meta-analysis
AUTHORS: Alves, C; Penedones, A; Mendes, D ; Marques, FB;
PUBLISHED: 2022, SOURCE: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, VOLUME: 28, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 24
17
TITLE: The Safety of Systemic Janus Kinase Inhibitors in Atopic Dermatitis: a Systematic Review and Network Meta-analysis
AUTHORS: Carlos Alves; Ana Penedones; Diogo Mendes ; Francisco Batel Marques;
PUBLISHED: 2022
INDEXED IN: CrossRef
IN MY: ORCID
18
TITLE: The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis  Full Text
AUTHORS: Alves, Carlos; Penedones, Ana; Mendes, Diogo ; Marques, Francisco Batel;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 78, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 18
19
TITLE: JAK inhibitors and the risk of cardiovascular and venous thromboembolism events among patients with rheumatoid arthritis: A network meta-analysis of clinical trials  Full Text
AUTHORS: Alves, C; Penedones, A; Mendes, D ; Marques, FB;
PUBLISHED: 2021, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 30
INDEXED IN: WOS
20
TITLE: RISK OF CARDIOVASCULAR AND VENOUS THROMBOEMBOLISM EVENTS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS  Full Text
AUTHORS: Penedones, A; Alves, C; Mendes, D ; Batel Marques, F;
PUBLISHED: 2021, SOURCE: EACPT Virtual Meeting - Focus on Progress in Clinical Pharmacology in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 77, ISSUE: SUPPL 1
INDEXED IN: WOS
Page 2 of 8. Total results: 73.